Latest filing published 29 Aug 2023 for Sutro Biopharma, INC., €67k.
Filing timeline
BuySaleInsider track record
Brunilda Shtylla: trading record in brief
Brunilda Shtylla appears in our data through filings on Sutro Biopharma, Inc. shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 3 March 2023 and the latest from 28 August 2023.
Every open-market trade on record is a sale: 2 sales worth €116k. The rest of the record consists of 1 share grant and 2 option exercises.
On 29 August 2023 came the latest disclosure, an open-market sale for €67k in Sutro Biopharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brunilda Shtylla
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,428 shares@ US$4.705457.6% of flowCommon StockSEC:0001209191-23-047608:0
- 11,613 shares@ US$4.588142.4% of flowCommon StockSEC:0001209191-23-047512:0
- 4,375 sharesCommon StockSEC:0001209191-23-016818:1
- 4,536 shares@ US$5.7917.6% of flowCommon StockSEC:0001209191-23-016818:2
- 6,750 sharesCommon StockSEC:0001209191-23-016818:0
5 of 5 declarations
